Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average: 2019-2025

Historic Assets Average for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $103.1 million.

  • Eton Pharmaceuticals' Assets Average rose 204.72% to $103.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.1 million, marking a year-over-year increase of 204.72%. This contributed to the annual value of $53.9 million for FY2024, which is 90.00% up from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Assets Average is $103.1 million, which was up 11.03% from $92.9 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Assets Average ranged from a high of $103.1 million in Q3 2025 and a low of $22.3 million during Q3 2022.
  • Moreover, its 3-year median value for Assets Average was $31.6 million (2023), whereas its average is $49.4 million.
  • In the last 5 years, Eton Pharmaceuticals' Assets Average dropped by 24.31% in 2022 and then spiked by 204.72% in 2025.
  • Quarterly analysis of 5 years shows Eton Pharmaceuticals' Assets Average stood at $27.0 million in 2021, then declined by 13.91% to $23.3 million in 2022, then surged by 35.91% to $31.6 million in 2023, then surged by 76.97% to $56.0 million in 2024, then surged by 204.72% to $103.1 million in 2025.
  • Its Assets Average was $103.1 million in Q3 2025, compared to $92.9 million in Q2 2025 and $80.1 million in Q1 2025.